Is Leukemia going to be the next cancer to become very curable? Gene therapy to modify immune cells makes them attack leukemia very effectively. 88% success rate against leukemia.
NEW YORK, February 19, 2014 — Investigators from Memorial Sloan Kettering Cancer Center have reported more encouraging news about one of the most exciting methods of cancer treatment today. The largest clinical study ever conducted to date of patients with advanced leukemia found that 88 percent achieved complete remissions after being treated with genetically modified versions of their own immune cells. The results were published today in Science Translational Medicine.
"These extraordinary results demonstrate that cell therapy is a powerful treatment for patients who have exhausted all conventional therapies," said Michel Sadelain, MD, PhD, Director of the Center for Cell Engineering at Memorial Sloan Kettering and one of the study's senior authors. "Our initial findings have held up in a larger cohort of patients, and we are already looking at new clinical studies to advance this novel therapeutic approach in fighting cancer."
Can we have this story repeated for about a couple dozen other cancers?
|Share |||Randall Parker, 2014 February 24 10:08 PM|